Effectiveness and Safety of Nadroparin Therapy in Preterm and Term Neonates with Venous Thromboembolism

Introduction: Optimal neonatal nadroparin dosages to treat venous thromboembolism (VTE) are unknown. Objective: To evaluate therapeutic nadroparin dosages to reach therapeutic target ranges (TTR: 0.5–1.0 International Unit (IU)/mL) and the effectiveness and safety of nadroparin in neonatal VTE. Meth...

Descripción completa

Detalles Bibliográficos
Autores principales: Sol, Jeanine, Boerma, Marit, Klaassen, Irene, Simons, Sinno, Witjes, Bregje, Wildschut, Enno, Reiss, Irwin, van Ommen, Cornelia Heleen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038284/
https://www.ncbi.nlm.nih.gov/pubmed/33918440
http://dx.doi.org/10.3390/jcm10071483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038284/
https://www.ncbi.nlm.nih.gov/pubmed/33918440
http://dx.doi.org/10.3390/jcm10071483

Ejemplares similares